Company intelligence / Profile preview

Humex

Brea, CA, United States

Ownership: Private
Development stage: Other

Overview

Humex offers commercialized products for anti-aging, skin rejuvenation, and scalp/hair issues, with regenerative medicine (stem cell-based cosmetics) capabilities. No clinical trial results found; the company is focused on distribution and contract manufacturing rather than innovative pharmaceuticals or clinical-stage therapeutics.

Therapeutic areas: DermatologyOther
Modalities: CosmeceuticalDeviceBiologicSmall moleculeStem cell-based therapy
Industry: Contract Manufacturing Organization

Partnerships

RNL Bio (stem cell/cosmetics collaboration, historical affiliation)Provimex (merged entity that formed HEET Biocell Group, historical)

Beyond the preview

Go deeper on Humex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Humex.

Explore the full profile